W P Petros, O M Colvin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » BiotransformationCyclophosphamide/administration & dosageCyclophosphamide/adverse effectsCyclophosphamide/metabolismCyclophosphamide/pharmacokineticsDose-Response Relationship, DrugDrug InteractionsDrug MonitoringHumansTherapeutic Equivalency
Substances： See more » Cyclophosphamide
Year: 1999 PMID： 10213204
Source DB: PubMed Journal: Clin Cancer Res ISSN： 1078-0432 Impact factor: 12.531